Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. [electronic resource]
- AIDS (London, England) Jan 2008
- 67-74 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1473-5571
10.1097/QAD.0b013e3282f2306e doi
Adult Alkynes Anemia Anti-HIV Agents--adverse effects Antiretroviral Therapy, Highly Active Benzoxazines--therapeutic use Cohort Studies Cyclopropanes Developing Countries Dizziness--chemically induced Drug Tolerance Female HIV Infections--drug therapy HIV-1 Humans Lamivudine--therapeutic use Male Middle Aged Nausea--chemically induced Neutropenia--chemically induced Prospective Studies South Africa Treatment Outcome Viral Load Vomiting--chemically induced Zidovudine--therapeutic use